Peanut Allergy Treatment From Aimmune Gets FDA Panel Nod – Investor's Business Daily

This post was originally published on this site

[unable to retrieve full-text content]Peanut Allergy Treatment From Aimmune Gets FDA Panel Nod  Investor’s Business Daily

A Food and Drug Administration panel determined Friday the benefits of Aimmune Therapeutics’ peanut allergy treatment outweigh the risks.

This post was originally published on *this site*